tiprankstipranks
Advertisement
Advertisement
Haixi Pharmaceuticals Launches Phase III Trial for Novel Osteosarcoma Drug
PremiumCompany AnnouncementsHaixi Pharmaceuticals Launches Phase III Trial for Novel Osteosarcoma Drug
24d ago
Haixi Pharma Initiated at Buy on Innovative Retinal and Oncology Pipeline; DCF‑Backed Target Price Set at HK$280
Premium
Ratings
Haixi Pharma Initiated at Buy on Innovative Retinal and Oncology Pipeline; DCF‑Backed Target Price Set at HK$280
2M ago
Fujian Haixi Pharmaceuticals Overhauls Governance as Shareholders Back All AGM Resolutions
Premium
Company Announcements
Fujian Haixi Pharmaceuticals Overhauls Governance as Shareholders Back All AGM Resolutions
2M ago
Fujian Haixi Advances First-in-Class Oral Retinal Drug HXP056 Into Phase II
PremiumCompany AnnouncementsFujian Haixi Advances First-in-Class Oral Retinal Drug HXP056 Into Phase II
4M ago
Fujian Haixi Pharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Final Dividend
Premium
Company Announcements
Fujian Haixi Pharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Final Dividend
5M ago
Fujian Haixi Pharmaceuticals Revamps Hong Kong Company Secretarial Roles
Premium
Company Announcements
Fujian Haixi Pharmaceuticals Revamps Hong Kong Company Secretarial Roles
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100